Impact of Preoperative Opioid Use on Patient-Reported Outcomes after Revision Total Knee Arthroplasty: A Propensity Matched Analysis

Eitan Ingall; Christian Klemt; Christopher M. Melnic; Wayne B. Cohen-Levy; Venkatsaiakhil Tirumala; Young-Min Kwon

doi:10.1055/s-0041-1729966

The Journal of Knee Surgery, Table of Contents

J Knee Surg 2023; 36(02): 115-120
DOI: 10.1055/s-0041-1729966

Original Article

Impact of Preoperative Opioid Use on Patient-Reported Outcomes after Revision Total Knee Arthroplasty: A Propensity Matched Analysis

Authors

Eitan Ingall

¹Department of Orthopaedic Surgery, Bioengineering Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
Christian Klemt

¹Department of Orthopaedic Surgery, Bioengineering Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
Christopher M. Melnic

¹Department of Orthopaedic Surgery, Bioengineering Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
Wayne B. Cohen-Levy

¹Department of Orthopaedic Surgery, Bioengineering Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
Venkatsaiakhil Tirumala

¹Department of Orthopaedic Surgery, Bioengineering Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
Young-Min Kwon

¹Department of Orthopaedic Surgery, Bioengineering Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

Abstract

This is a retrospective study. Prior studies have characterized the deleterious effects of narcotic use in patients undergoing primary total knee arthroplasty (TKA). While there is an increasing revision arthroplasty burden, data on the effect of narcotic use in the revision surgery setting remain limited. Our aim was to characterize the effect of active narcotic use at the time of revision TKA on patient-reported outcome measures (PROMs). A total of 330 consecutive patients who underwent revision TKA and completed both pre- and postoperative PROMs was identified. Due to differences in baseline characteristics, 99 opioid users were matched to 198 nonusers using the nearest-neighbor propensity score matching. Pre- and postoperative knee disability and osteoarthritis outcome score physical function (KOOS-PS), patient reported outcomes measurement information system short form (PROMIS SF) physical, PROMIS SF mental, and physical SF 10A scores were evaluated. Opioid use was identified by the medication reconciliation on the day of surgery. Propensity score–matched opioid users had significantly lower preoperative PROMs than the nonuser for KOOS-PS (45.2 vs. 53.8, p < 0.01), PROMIS SF physical (37.2 vs. 42.5, p < 0.01), PROMIS SF mental (44.2 vs. 51.3, p < 0.01), and physical SF 10A (34.1 vs. 36.8, p < 0.01). Postoperatively, opioid-users demonstrated significantly lower scores across all PROMs: KOOS-PS (59.2 vs. 67.2, p < 0.001), PROMIS SF physical (43.2 vs. 52.4, p < 0.001), PROMIS SF mental (47.5 vs. 58.9, p < 0.001), and physical SF 10A (40.5 vs. 49.4, p < 0.001). Propensity score–matched opioid-users demonstrated a significantly smaller absolute increase in scores for PROMIS SF Physical (p = 0.03) and Physical SF 10A (p < 0.01), as well as an increased hospital length of stay (p = 0.04). Patients who are actively taking opioids at the time of revision TKA report significantly lower preoperative and postoperative outcome scores. These patients are more likely to have longer hospital stays. The apparent negative effect on patient reported outcomes after revision TKA provides clinically useful data for surgeons in engaging patients in a preoperative counseling regarding narcotic use prior to revision TKA to optimize outcomes.

Keywords

opioid - patient-reported outcomes measures - revision knee arthroplasty

Full Text

References

References
1 Bonner BE, Castillo TN, Fitz DW, Zhao JZ, Klemt C, Kwon Y-M. Preoperative opioid use negatively affects patient-reported outcomes after primary total hip arthroplasty. J Am Acad Orthop Surg 2019; 27 (22) e1016-e1020
2 Zywiel MG, Stroh DA, Lee SY, Bonutti PM, Mont MA. Chronic opioid use prior to total knee arthroplasty. J Bone Joint Surg Am 2011; 93 (21) 1988-1993
3 Crowninshield RD, Rosenberg AG, Sporer SM. Changing demographics of patients with total joint replacement. Clin Orthop Relat Res 2006; 443 (443) 266-272
4 Hamilton DF, Howie CR, Burnett R, Simpson AHRW, Patton JT. Dealing with the predicted increase in demand for revision total knee arthroplasty: challenges, risks and opportunities. Bone Joint J 2015; 97-B (06) 723-728
5 Smith SR, Bido J, Collins JE, Yang H, Katz JN, Losina E. Impact of preoperative opioid use on total knee arthroplasty outcomes. J Bone Joint Surg Am 2017; 99 (10) 803-808
6 Pivec R, Issa K, Naziri Q, Kapadia BH, Bonutti PM, Mont MA. Opioid use prior to total hip arthroplasty leads to worse clinical outcomes. Int Orthop 2014; 38 (06) 1159-1165
7 Davis AM, Perruccio AV, Canizares M. et al. Comparative, validity and responsiveness of the HOOS-PS and KOOS-PS to the WOMAC physical function subscale in total joint replacement for osteoarthritis. Osteoarthritis Cartilage 2009; 17 (07) 843-847
8 Davis AM, Perruccio AV, Canizares M. et al. The development of a short measure of physical function for hip OA HOOS-Physical Function Shortform (HOOS-PS): an OARSI/OMERACT initiative. Osteoarthritis Cartilage 2008; 16 (05) 551-559
9 Ramkumar PN, Harris JD, Noble PC. Patient-reported outcome measures after total knee arthroplasty: a systematic review. Bone Joint Res 2015; 4 (07) 120-127
10 Finch DJ, Martin BI, Franklin PD, Magder LS, Pellegrini Jr. VDJ. PEPPER Investigators. Patient-reported outcomes following total hip arthroplasty: a multicenter comparison based on surgical approaches. J Arthroplasty 2020; 35 (04) 1029-1035.e3
11 Stiegel KR, Lash JG, Peace AJ, Coleman MM, Harrington MA, Cahill CW. Early experience and results using patient-reported outcomes measurement information system scores in primary total hip and knee arthroplasty. J Arthroplasty 2019; 34 (10) 2313-2318
12 Kurtz SM, Lau E, Ong K, Zhao K, Kelly M, Bozic KJ. Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop Relat Res 2009; 467 (10) 2606-2612
13 Politzer CS, Kildow BJ, Goltz DE, Green CL, Bolognesi MP, Seyler TM. Trends in opioid utilization before and after total knee arthroplasty. J Arthroplasty 2018; 33 (7S): S147-S153
14 Postler AE, Beyer F, Wegner T. et al. Patient-reported outcomes after revision surgery compared to primary total hip arthroplasty. Hip Int 2017; 27 (02) 180-186
15 Cella D, Yount S, Rothrock N. et al; PROMIS Cooperative Group. The Patient-reported outcomes measurement information system (PROMIS): progress of an NIH roadmap cooperative group during its first two years. Med Care 2007; 45 (05, Suppl 1): S3-S11
16 Bohannon RW, DePasquale L. Physical Functioning Scale of the Short-Form (SF) 36: internal consistency and validity with older adults. J Geriatr Phys Ther 2010; 33 (01) 16-18
17 Nilsdotter AK, Lohmander LS, Klässbo M, Roos EM. Hip disability and osteoarthritis outcome score (HOOS)--validity and responsiveness in total hip replacement. BMC Musculoskelet Disord 2003; 4: 10
18 Tan TL, Goswami K, Kheir MM, Xu C, Wang Q, Parvizi J. Surgical treatment of chronic periprosthetic joint infection: fate of spacer exchanges. J Arthroplasty 2019; 34 (09) 2085-2090.e1
19 Yost KJ, Eton DT, Garcia SF, Cella D. Minimally important differences were estimated for six patient-reported outcomes measurement information system-cancer scales in advanced-stage cancer patients. J Clin Epidemiol 2011; 64 (05) 507-516
20 Rozell JC, Courtney PM, Dattilo JR, Wu CH, Lee G-C. Preoperative opiate use independently predicts narcotic consumption and complications after total joint arthroplasty. J Arthroplasty 2017; 32 (09) 2658-2662
21 Carpinelli RN, Otto RM. Strength training. Single versus multiple sets. Sports Med 1998; 26 (02) 73-84
22 Sing DC, Barry JJ, Cheah JW, Vail TP, Hansen EN. Long-acting opioid use independently predicts perioperative complication in total joint arthroplasty. J Arthroplasty 2016; 31 (9, Suppl): 170-174.e1
23 Ben-Ari A, Chansky H, Rozet I. Preoperative opioid use is associated with early revision after total knee arthroplasty: a study of male patients treated in the veterans affairs system. J Bone Joint Surg Am 2017; 99 (01) 1-9
24 Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89 (04) 780-785
25 Peterson J, Sodhi N, Khlopas A. et al. A comparison of relative value units in primary versus revision total knee arthroplasty. J Arthroplasty 2018; 33 (7S): S39-S42
26 Wilson JM, Farley KX, Bradbury TL, Erens GA, Guild GN. Preoperative opioid use is a risk factor for complication and increased healthcare utilization following revision total knee arthroplasty. Knee 2020; 27 (04) 1121-1127
27 Bernstein J, Feng J, Mahure S, Schwarzkopf R, Long W. Revision total knee arthroplasty is associated with significantly higher opioid consumption as compared with primary total knee arthroplasty in the acute postoperative period. Arthroplast Today 2020; 6 (02) 172-175
28 Carroll IR, Angst MS, Clark JD. Management of perioperative pain in patients chronically consuming opioids. Reg Anesth Pain Med 2004; 29 (06) 576-591
29 de Boer HD, Detriche O, Forget P. Opioid-related side effects: Postoperative ileus, urinary retention, nausea and vomiting, and shivering. A review of the literature. Best Pract Res Clin Anaesthesiol 2017; 31 (04) 499-504
30 Halawi MJ, Vovos TJ, Green CL, Wellman SS, Attarian DE, Bolognesi MP. Opioid-based analgesia: impact on total joint arthroplasty. J Arthroplasty 2015; 30 (12) 2360-2363
31 Zarling BJ, Sikora-Klak J, Bergum C, Markel DC. How do preoperative medications influence outcomes after total joint arthroplasty?. J Arthroplasty 2017; 32 (9S): S259-S262
32 Bozic KJ, Lau E, Ong K. et al. Risk factors for early revision after primary total hip arthroplasty in Medicare patients. Clin Orthop Relat Res 2014; 472 (02) 449-454
33 Roche M, Law TY, Sodhi N. et al. Incidence of drug abuse in revision total knee arthroplasty population. J Knee Surg 2018; 31 (10) 928-933